glp 1 microdosing for autoimmune GLP-1 Medications Arthritis & Disease Microdosing GLP-1 for Hashimoto's: Evidence,

Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice

Gradual Uptitration: Patients are closely monitored as the dose is gradually increased in increments of 0.1mg every few weeks, based on individual response and tolerability

Zealands other weight loss drug in the clinic is petrelintide

Figure S3: (A) Individual study result of primary outcome: incidence of hearing loss, (B) Individual study result of primary outcome: incidence of hearing loss in subgroup of dosage, (C) Individual study result of drop-out rate

Reports from separate cases have shown that dulaglutide can cause PG and BP, which adds to the expanding research on autoimmune skin conditions related to GLP-1RA